Chantal Letourneau
About Chantal Letourneau
Chantal Letourneau serves as the Vice President of Clinical Operations for CNS Gene Therapy at Asklepios BioPharmaceutical, Inc., bringing extensive experience in clinical trial management from various pharmaceutical companies. Her background includes leadership roles at Apellis Pharmaceuticals, EnVivo Pharmaceuticals, Biogen Idec, and Shire Pharmaceuticals, among others, with a focus on developing therapies for complex conditions.
Current Role at Asklepios BioPharmaceutical
Chantal Letourneau serves as the Vice President of Clinical Operations for CNS Gene Therapy at Asklepios BioPharmaceutical, Inc. (AskBio). She has held this position since 2022, focusing on overseeing clinical operations related to central nervous system gene therapy projects. Her role involves managing clinical trials and ensuring the successful development of innovative therapies in this specialized area.
Previous Experience at Apellis Pharmaceuticals
Prior to her current role, Letourneau worked at Apellis Pharmaceuticals as the Head of Global Clinical Operations from 2020 to 2022. During her tenure, she was responsible for leading clinical operations on a global scale, contributing to the advancement of the company's clinical programs in Waltham, Massachusetts.
Clinical Operations Expertise
Letourneau possesses extensive expertise in managing clinical operations across various therapeutic areas, including CNS gene therapy, schizophrenia, and hemophilia. Her experience spans both large pharmaceutical companies and smaller biotech firms, allowing her to develop a comprehensive understanding of clinical trial management.
Educational Background
Chantal Letourneau earned her Bachelor of Arts degree from the University of Richmond, where she studied Psychology, Criminal Justice, and Neuroscience from 1999 to 2003. This educational foundation has contributed to her strong analytical skills and understanding of clinical research methodologies.
Career Progression in Clinical Research
Letourneau's career in clinical research began at Massachusetts General Hospital, where she worked as a Senior Clinical Research Coordinator in Pediatric Psychopharmacology from 2003 to 2005. She has since held various roles, including Clinical Trial Manager positions at companies such as Biogen Idec, EnVivo Pharmaceuticals, and Wyeth Research, demonstrating her commitment to advancing clinical operations in the pharmaceutical industry.